-
Je něco špatně v tomto záznamu ?
Characterization of molecular mechanisms underlying the axonal Charcot-Marie-Tooth neuropathy caused by MORC2 mutations
P. Sancho, L. Bartesaghi, O. Miossec, F. García-García, L. Ramírez-Jiménez, A. Siddell, E. Åkesson, E. Hedlund, P. Laššuthová, SI. Pascual-Pascual, T. Sevilla, M. Kennerson, V. Lupo, R. Chrast, C. Espinós,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NV16-30206A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Free Medical Journals
od 1996 do Před 1 rokem
Open Access Digital Library
od 1996-01-01
PubMed
30624633
DOI
10.1093/hmg/ddz006
Knihovny.cz E-zdroje
- MeSH
- axony metabolismus patologie MeSH
- Charcotova-Marieova-Toothova nemoc genetika patologie MeSH
- embryonální kmenové buňky metabolismus MeSH
- fibroblasty metabolismus patologie MeSH
- krysa rodu rattus MeSH
- lidé MeSH
- mutace genetika MeSH
- nervové kmenové buňky MeSH
- nervové receptory metabolismus patologie MeSH
- regulace genové exprese genetika MeSH
- transkripční faktory genetika MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Mutations in MORC2 lead to an axonal form of Charcot-Marie-Tooth (CMT) neuropathy type 2Z. To date, 31 families have been described with mutations in MORC2, indicating that this gene is frequently involved in axonal CMT cases. While the genetic data clearly establish the causative role of MORC2 in CMT2Z, the impact of its mutations on neuronal biology and their phenotypic consequences in patients remains to be clarified. We show that the full-length form of MORC2 is highly expressed in both embryonic and adult human neural tissues and that Morc2 expression is dynamically regulated in both the developing and the maturing murine nervous system. To determine the effect of the most common MORC2 mutations, p.S87L and p.R252W, we used several in vitro cell culture paradigms. Both mutations induced transcriptional changes in patient-derived fibroblasts and when expressed in rodent sensory neurons. These changes were more pronounced and accompanied by abnormal axonal morphology, in neurons expressing the MORC2 p.S87L mutation, which is associated with a more severe clinical phenotype. These data provide insight into the neuronal specificity of the mutated MORC2-mediated phenotype and highlight the importance of neuronal cell models to study the pathophysiology of CMT2Z.
Department of Neuroscience Karolinska Institutet Stockholm Sweden
Department of Pediatric Neurology Hospital Universitario La Paz Madrid Spain
Unit of Bioinformatics and Biostatistics Centro de Investigación Príncipe Felipe Valencia Spain
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006660
- 003
- CZ-PrNML
- 005
- 20200522110535.0
- 007
- ta
- 008
- 200511s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/hmg/ddz006 $2 doi
- 035 __
- $a (PubMed)30624633
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Sancho, Paula $u Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
- 245 10
- $a Characterization of molecular mechanisms underlying the axonal Charcot-Marie-Tooth neuropathy caused by MORC2 mutations / $c P. Sancho, L. Bartesaghi, O. Miossec, F. García-García, L. Ramírez-Jiménez, A. Siddell, E. Åkesson, E. Hedlund, P. Laššuthová, SI. Pascual-Pascual, T. Sevilla, M. Kennerson, V. Lupo, R. Chrast, C. Espinós,
- 520 9_
- $a Mutations in MORC2 lead to an axonal form of Charcot-Marie-Tooth (CMT) neuropathy type 2Z. To date, 31 families have been described with mutations in MORC2, indicating that this gene is frequently involved in axonal CMT cases. While the genetic data clearly establish the causative role of MORC2 in CMT2Z, the impact of its mutations on neuronal biology and their phenotypic consequences in patients remains to be clarified. We show that the full-length form of MORC2 is highly expressed in both embryonic and adult human neural tissues and that Morc2 expression is dynamically regulated in both the developing and the maturing murine nervous system. To determine the effect of the most common MORC2 mutations, p.S87L and p.R252W, we used several in vitro cell culture paradigms. Both mutations induced transcriptional changes in patient-derived fibroblasts and when expressed in rodent sensory neurons. These changes were more pronounced and accompanied by abnormal axonal morphology, in neurons expressing the MORC2 p.S87L mutation, which is associated with a more severe clinical phenotype. These data provide insight into the neuronal specificity of the mutated MORC2-mediated phenotype and highlight the importance of neuronal cell models to study the pathophysiology of CMT2Z.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a axony $x metabolismus $x patologie $7 D001369
- 650 _2
- $a Charcotova-Marieova-Toothova nemoc $x genetika $x patologie $7 D002607
- 650 _2
- $a embryonální kmenové buňky $x metabolismus $7 D053595
- 650 _2
- $a fibroblasty $x metabolismus $x patologie $7 D005347
- 650 _2
- $a regulace genové exprese $x genetika $7 D005786
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mutace $x genetika $7 D009154
- 650 _2
- $a nervové kmenové buňky $7 D058953
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a nervové receptory $x metabolismus $x patologie $7 D011984
- 650 _2
- $a transkripční faktory $x genetika $7 D014157
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bartesaghi, Luca $u Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden. Department of Clinical Neuroscience, Karolinska Institutet, 17165 Stockholm, Sweden.
- 700 1_
- $a Miossec, Olivia $u Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden. Department of Clinical Neuroscience, Karolinska Institutet, 17165 Stockholm, Sweden.
- 700 1_
- $a García-García, Francisco $u Unit of Bioinformatics and Biostatistics, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
- 700 1_
- $a Ramírez-Jiménez, Laura $u Department of Genomics and Translational Genetics, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
- 700 1_
- $a Siddell, Anna $u Northcott Neuroscience Laboratory, ANZAC Research Institute, Concord NSW, Australia. Sydney Medical School, University of Sydney, Sydney NSW, Australia.
- 700 1_
- $a Åkesson, Elisabet $u Division of Neurodegeneration, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden. The R&D Unit, Stiftelsen Stockholms Sjukhemm, 14152, Sweden.
- 700 1_
- $a Hedlund, Eva $u Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Laššuthová, Petra $u Department of Pediatric Neurology, DNA Laboratory, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.
- 700 1_
- $a Pascual-Pascual, Samuel I $u Department of Pediatric Neurology, Hospital Universitario La Paz, Madrid, Spain.
- 700 1_
- $a Sevilla, Teresa $u Department of Neurology, Hospital Universitari i Politècnic La Fe, and CIBER of Rare Diseases (CIBERER), Valencia, Spain. Department of Medicine, University of Valencia, Valencia, Spain.
- 700 1_
- $a Kennerson, Marina $u Northcott Neuroscience Laboratory, ANZAC Research Institute, Concord NSW, Australia. Sydney Medical School, University of Sydney, Sydney NSW, Australia. Molecular Medicine Laboratory, Concord Hospital, Concord NSW, Australia.
- 700 1_
- $a Lupo, Vincenzo $u Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain. Department of Genomics and Translational Genetics, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain. INCLIVA & IIS-La Fe Rare Diseases Joint Units, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
- 700 1_
- $a Chrast, Roman $u Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden. Department of Clinical Neuroscience, Karolinska Institutet, 17165 Stockholm, Sweden.
- 700 1_
- $a Espinós, Carmen $u Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain. Department of Genomics and Translational Genetics, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain. INCLIVA & IIS-La Fe Rare Diseases Joint Units, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
- 773 0_
- $w MED00002077 $t Human molecular genetics $x 1460-2083 $g Roč. 28, č. 10 (2019), s. 1629-1644
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30624633 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200522110533 $b ABA008
- 999 __
- $a ok $b bmc $g 1525518 $s 1096716
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 28 $c 10 $d 1629-1644 $e 20190515 $i 1460-2083 $m Human molecular genetics $n Hum Mol Genet $x MED00002077
- GRA __
- $a NV16-30206A $p MZ0
- LZP __
- $a Pubmed-20200511